Stimulatory and inhibitory receptor interactions in xenotransplantation

Current Opinion in Organ Transplantation

Volumn 15, Issue 2, 2010, Pages 219-223

  Plege, Annegret ^a   Schwinzer, Reinhard ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Monocytes macrophages; Natural killer cells; Positive and negative signaling; T cells; Xenograft rejection

Indexed keywords

BINDING PROTEIN; CD94 ANTIGEN; HLA ANTIGEN; HLA ANTIGEN CLASS E; LIGAND; NATURAL KILLER CELL RECEPTOR; NATURAL KILLER CELL RECEPTOR NKG2A; REGULATOR PROTEIN; UL16 BINDING PROTEIN 1; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; CELL ACTIVATION; CELL ACTIVITY; CELLULAR IMMUNITY; CYTOLYSIS; GRAFT REJECTION; HUMAN; IMMUNOMODULATION; IMMUNOREACTIVITY; LIGAND BINDING; MACROPHAGE; MONOCYTE; NATURAL KILLER CELL; NONHUMAN; PROTEIN INTERACTION; REVIEW; SWINE; T LYMPHOCYTE; XENOTRANSPLANTATION;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNITY, CELLULAR; KILLER CELLS, NATURAL; LIGANDS; MACROPHAGES; MONOCYTES; RECEPTORS, IMMUNOLOGIC; SIGNAL TRANSDUCTION; SPECIES SPECIFICITY; SWINE; T-LYMPHOCYTES; TRANSPLANTATION TOLERANCE; TRANSPLANTATION, HETEROLOGOUS;

EID: 77952280596     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0b013e328336b8e5     Document Type: Review

References (45)

1. Kuwaki K, Tseng YL, Dor FJ, et al. Heart transplantation in baboons using alpha1, 3-galactosyltransferase gene-knockout pigs as donors: initial experience. Nat Med 2005;11:29-31. (Pubitemid 40215833)
2. Yamada K, Yazawa K, Shimizu A, et al. Marked prolongation of porcine renal xenograft survival in baboons through the use of alpha1, 3-galactosyltransfer-ase gene-knockout donors and the cotransplantation of vascularized thymic tissue. Nat Med 2005;11:32-34. (Pubitemid 40215834)
3. Le Bas-Bernardet S, Blancho G. Current cellular immunological hurdles in pig-to-primate xenotransplantation. Transpl Immunol 2009;21:60-64.
4. Itescu S, Kwiatkowski P, Artrip JH, et al. Role of natural killer cells, macrophages, and accessory molecule interactions in the rejection of pig-to-primate xenografts beyond the hyperacute period. Hum Immunol 1998;59:275-286. (Pubitemid 28225986)
5. Hisashi Y, Yamada K, Kuwaki K, et al. Rejection of cardiac xenografts transplanted from alpha1, 3-galactosytransferase gene-knockout (GalT-KO) pigs to baboons. Am J Transplant 2008;8:2516-2526. The present study shows that in the absence of Gal, despite chronic immunosuppression, acute and chronic antibody and cell-mediated rejection occurs in the xenografts.
6. Yi S, Ouyang L, Ha H, et al. Involvement of CCR5 signaling in macrophage recruitment to porcine islet xenografts. Transplantation 2005;80:1468-1475. (Pubitemid 41803630)
7. Yi S, Wang Y, Chandra AP, et al. Requirement of MyD88 for macrophage-mediated islet xenograft rejection after adoptive transfer. Transplantation 2007;83:615-623. (Pubitemid 46440252)
8. Ide K, Ohdan H, Kobayashi T, et al. Antibody-and complement-independent phagocytotic and cytolytic activities of human macrophages toward porcine cells. Xenotransplantation 2005;12:181-188. (Pubitemid 40524978)
9. Ide K, Wang H, Tahara H, et al. Role for CD47-SIRPalpha signaling in xenograft rejection by macrophages. Proc Natl Acad Sci USA 2007;104: 5062-5066. (Pubitemid 47186176)
10. Wang H, VerHalen J, Madariaga ML, et al. Attenuation of phagocytosis of xenogeneic cells by manipulating CD47. Blood 2007;109:836-842. (Pubitemid 46105989)
11. Oldenborg PA, Zheleznyak A, Fang YF, et al. Role of CD47 as a marker of self on red blood cells. Science 2000;288:2051-2054. (Pubitemid 30397687)
12. Goodman DJ, Von Albertini M, Willson A, et al. Direct activation of porcine endothelial cells by human natural killer cells. Transplantation 1996;61:763-771. (Pubitemid 26097238)
13. Khalfoun B, Barrat D, Watier H, et al. Development of an ex vivo model of pig kidney perfused with human lymphocytes. Analysis of xenogeneic cellular reactions. Surgery 2000;128:447-457.
14. Quan D, Bravery C, Chavez G, et al. Identification, detection, and in vitro characterization of cynomolgus monkey natural killer cells in delayed xenograft rejection of hDAF transgenic porcine renal xenografts. Transplant Proc 2000;32:936-937. (Pubitemid 30601811)
15. Lilienfeld BG, Garcia-Borges C, Crew MD, Seebach JD. Porcine UL16-binding protein 1 expressed on the surface of endothelial cells triggers human NK cytotoxicity through NKG2D. J Immunol 2006;177:2146-2152. (Pubitemid 44200973)
16. Lilienfeld BG, Schildknecht A, Imbach LL, et al. Characterization of porcine UL16-binding protein 1 endothelial cell surface expression. Xenotransplantation 2008;15:136-144. (Pubitemid 351601119)
17. Tran PD, Christiansen D, Winterhalter A, et al. Porcine cells express more than one functional ligand for the human lymphocyte activating receptor NKG2D. Xenotransplantation 2008;15:321-332. This study demonstrates the expression of at least one further ligand to pULPB1 for human NKG2D on porcine renal epithelial and intestinal endothelial cells.
18. Forte P, Lilienfeld BG, Baumann BC, Seebach JD. Human NK cytotoxicity against porcine cells is triggered by NKp44 and NKG2D. J Immunol 2005;175:5463-5470. (Pubitemid 41456433)
19. Sullivan JA, Oettinger HF, Sachs DH, Edge AS. Analysis of polymorphism in porcine MHC class I genes: alterations in signals recognized by human cytotoxic lymphocytes. J Immunol 1997;159:2318-2326.
20. Seebach JD, Comrack C, Germana S, et al. HLA-Cw3 expression on porcine endothelial cells protects against xenogeneic cytotoxicity mediated by a subset of human NK cells. J Immunol 1997;159:3655-3661. (Pubitemid 127482126)
21. Forte P, Baumann BC, Schneider MK, Seebach JD. HLA-Cw4 expression on porcine endothelial cells reduces cytotoxicity and adhesion mediated by CD158a+ human NK cells. Xenotransplantation 2009;16:19-26. The authors show that the expression of HLA-Cw4 reduces the adhesion of human NK cells on pEC and that coexpression with HLA-Cw3 is not sufficient to completely overcome human antipig NK-mediated cytotoxicity in vitro.
22. Forte P, Baumann BC, Weiss EH, Seebach JD. HLA-E expression on porcine cells: protection from human NK cytotoxicity depends on peptide loading. Am J Transplant 2005;5:2085-2093. (Pubitemid 41648455)
23. Garcia P, Llano M, de Heredia AB, et al. Human T cell receptor-mediated recognition of HLA-E. Eur J Immunol 2002;32:936-944. (Pubitemid 34428808)
24. Lilienfeld BG, Crew MD, Forte P, et al. Transgenic expression of HLA-E single chain trimer protects porcine endothelial cells against human natural killer cell-mediated cytotoxicity. Xenotransplantation 2007;14:126-134. (Pubitemid 46457451)
25. Weiss EH, Lilienfeld BG, Muller S, et al. HLA-E/human beta2-microglobulin transgenic pigs: protection against xenogeneic human antipig natural killer cell cytotoxicity. Transplantation 2009;87:35-43. This study describes the generation of transgenic pigs expressing HLA and human β2-microglobulin on endothelial cells of many organs. In-vitro studies showed that lymphoblasts and endothelial cells derived from these transgenic pigs are effectively protected against human NK-cell-mediated cytotoxicity.
26. Rogers NJ, Jackson IM, Jordan WJ, et al. Cross-species costimulation: relative contributions of CD80, CD86, and CD40. Transplantation 2003;75:2068-2076.
27. Dorling A, Lombardi G, Binns R, Lechler RI. Detection of primary direct and indirect human antiporcine T cell responses using a porcine dendritic cell population. Eur J Immunol 1996;26:1378-1387. (Pubitemid 26001076)
28. Choi I, Kim SD, Cho B, et al. Xenogeneic interaction between human CD40L and porcine CD40 activates porcine endothelial cells through NF-kappaB signaling. Mol Immunol 2008;45:575-580. (Pubitemid 47332647)
29. Frauwirth KA, Alegre ML, Thompson CB. Induction of T cell anergy in the absence of CTLA-4/B7 interaction. J Immunol 2000;164:2987-2993.
30. Wekerle T, Kurtz J, Bigenzahn S, et al. Mechanisms of transplant tolerance induction using costimulatory blockade. Curr Opin Immunol 2002;14:592-600.
31. Hering BJ, Wijkstrom M, Graham ML, et al. Prolonged diabetes reversal after intraportal xenotransplantation of wild-type porcine islets in immunosup-pressed nonhuman primates. Nat Med 2006;12:301-303. (Pubitemid 43355076)
32. Cardona K, Korbutt GS, Milas Z, et al. Long-term survival of neonatal porcine islets in nonhuman primates by targeting costimulation pathways. Nat Med 2006;12:304-306. (Pubitemid 43355077)
33. Chen Y, Liu H, Liu Z, et al. Blockade of inducible costimulator pathway to prevent acute rejection in rat liver transplantation. Am J Surg 2009;198:244-249. These data demonstrate that RNA interference is a potent tool to downmodulate ICOS expression and protect allografts from acute rejection.
34. Burrell BE, Lu G, Li XC, Bishop DK. OX40 costimulation prevents allograft acceptance induced by CD40-CD40L blockade. J Immunol 2009;182: 379-390. These studies reveal both redundancy and key differences in function among costimulatory molecules.
35. Keir ME, Butte MJ, Freeman GJ, Sharpe AH. PD-1 and its ligands in tolerance and immunity. Annu Rev Immunol 2008;26:677-704. (Pubitemid 351600389)
36. del Rio ML, Buhler L, Gibbons C, et al. PD-1/PD-L1, PD-1/PD-L2, and other co-inhibitory signaling pathways in transplantation. Transpl Int 2008;21: 1015-1028.
37. Truong W, Plester JC, Hancock WW, et al. Negative and positive co-signaling with anti-BTLA (PJ196) and CTLA4Ig prolongs islet allograft survival. Transplantation 2007;84:1368-1372. (Pubitemid 351339328)
38. Yi KH, Chen L. Fine tuning the immune response through B7-H3 and B7-H4. Immunol Rev 2009;229:145-151.
39. + T cell activation.
40. Yuan CL, Xu JF, Tong J, et al. B7-H4 transfection prolongs beta-cell graft survival. Transpl Immunol 2009;21:143-149. This study indicates that expression of B7-H4 on β cells might be an approach to protect β cells from rejection.
41. Wang X, Hao J, Metzger DL, et al. Local expression of B7-H4 by recombinant adenovirus transduction in mouse islets prolongs allograft survival. Transplantation 2009;87:482-490. The present study shows that local expression of B7-H4 prolongs islet allograft survival, indicating that B7-H4 might be an interesting target structure for T-cell modulation after transplantation.
42. Wang CJ, Chou FC, Chu CH, et al. Protective role of programmed death 1 ligand 1 (PD-L1) in nonobese diabetic mice: the paradox in transgenic models. Diabetes 2008;57:1861-1869. This study demonstrates the protective potential of transgenic PD-L1 on pancreatic β cells in autoimmune diabetes and illustrates the role of PD-L1 in down-regulating T-cell responses.
43. Dudler J, Li J, Pagnotta M, et al. Gene transfer of programmed death ligand-1. Ig prolongs cardiac allograft survival. Transplantation 2006;82:1733-1737. (Pubitemid 46035660)
44. Jeon DH, Oh K, Oh BC, et al. Porcine PD-L1: cloning, characterization, and implications during xenotransplantation. Xenotransplantation 2007;14:236-242. (Pubitemid 46699576)
45. Plege A, Borns K, Baars W, Schwinzer R. Suppression of human T-cell activation and expansion of regulatory T cells by pig cells overexpressing PD-ligands. Transplantation 2009;87:975-982. The findings of this study imply that PD-1/PD-ligand pathways are interesting targets to prevent human antipig T-cell responses after xenotransplantation.